NDC Package 0093-7227-72 Ribavirin

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

0093-7227-72

Package Description:

42 CAPSULE in 1 BOTTLE

Product Code:

0093-7227

Proprietary Name:

Ribavirin

Usage Information:

Ribavirin is used in combination with other antiviral medications (such as interferon, sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. Ribavirin works by reducing the amount of hepatitis C virus in your body, which may help your liver recover. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (including the use of latex condoms) to lower the risk of passing the virus to others.

11-Digit NDC Billing Format:

00093722772

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

42 EA

Labeler Name:

Teva Pharmaceuticals Usa Inc

Sample Package:

FDA Application Number:

ANDA076277

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

10-04-2004

End Marketing Date:

11-30-2015

Listing Expiration Date:

11-30-2015

Exclude Flag:

Code Structure:

0093 - Teva Pharmaceuticals Usa Inc
- 0093-7227 - Ribavirin
  - 0093-7227-72 - 42 CAPSULE in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
0093-7227-58	84 CAPSULE in 1 BOTTLE
0093-7227-63	56 CAPSULE in 1 BOTTLE
0093-7227-77	70 CAPSULE in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0093-7227-72?

The NDC Packaged Code 0093-7227-72 is assigned to a package of 42 capsule in 1 bottle of Ribavirin, labeled by Teva Pharmaceuticals Usa Inc. The product's dosage form is and is administered via form.

Is NDC 0093-7227 included in the NDC Directory?

No, Ribavirin with product code 0093-7227 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Teva Pharmaceuticals Usa Inc on October 04, 2004 and its listing in the NDC Directory is set to expire on November 30, 2015 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0093-7227-72?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 42.

What is the 11-digit format for NDC 0093-7227-72?

The 11-digit format is 00093722772. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
4-4-2	0093-7227-72	5-4-2	00093-7227-72

Table of Contents